S. cerevisiae (bakery) |
β-1,3 y β-1,6 |
100 μg/mL |
Gadus morhua
|
- |
- |
[88] |
- |
Increased antibacterial genes BPI/LBP and g-type lysozyme, pro-inflammatory cytokines il-1β and il-8, and antioxidants CAT and Cu/Zn-SOD |
S. cerevisiae (MacroGard® and Zymosan) |
β-1,3 y β-1,6 |
10–100 μg/mL |
Cyprinus carpio carpio
|
- |
|
[47] |
- |
Increased production of reactive radicals (oxygen and nitrogen), expression of cytokine genes (il-1 β, il-6 and il-11) |
S. cerevisiae (Zymosan) |
β-1,3 y β-1,6 |
50 μg/mL |
Lutjanus peru
|
Vibrio parahaemolyticus
|
- |
[60] |
1 × 108 cell mL−1
|
Stimulated the expression upstream of ilf2, ilf3, can, and downstream of cd3, tcrβ, il-6, il-12 |
Yarrowia lipolytica N6 (marine) |
β-1,3 y β-1,6 |
200 μg/mL |
Lutjanus peru
|
Vibrio parahaemolyticus
|
Immunized and challenged leukocytes |
[89] |
1 × 108 cell mL−1
|
Increased ON, SOD, CAT, PO. Regulated pro-inflammatory (il-1β, il-8, il-12, il-17) and anti-inflammatory (il-6, il-10) cytokines |
Sterigmatomyces halophilus (marine) |
β-1,3 y β-1,6 |
200 μg/mL |
Lutjanus peru
|
Aeromonas hydrophila
|
Immunized and challenged leukocytes |
[18] |
1 × 108 cell mL−1
|
Increased phagocytic activity, NBT, NO, PO, SOD, CAT. Genetic experimentation in cytokines il-1β, il-10, and il-17 |
Debaryomyces hansenii BCS004 |
β-1,3 y β-1,6 |
100 μg/mL |
Lutjanus peru
|
- |
Increased cell viability with doses of 50, 100 and 500 μg/mL |
[26] |
- |
- |
Cystobasidium benthicum
|
β-1,3 y β-1,6 |
50, 100 and 200 μg/mL |
Totoaba macdonaldi
|
- |
Increased phagocytic activity, MPO, production of intracellular-mitochondrial ROS, NO, SOD, and gene expression of tlr2, clec17a, mmr, il-β, and 1csf1r2 |
[22] |